Regeneron Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
All right. Good morning, and once again, welcome to the 39th Annual, and first and hopefully only time, Virtual JPMorgan Healthcare Conference.
My name is Cory Kasimov, I'm the senior large-cap biotech analyst, and it's my pleasure to introduce our next company to present, which is Regeneron. Representing Regeneron for the presentation are the company's co-founders: CEO Len Schleifer and CSO George Yancopoulos.
Please note that following this presentation, we will have a Q&A session right here in the same Zoom room. So there's no need to fight the crowd to get to the [Burge] room. (Operator Instructions)
So with that, Len, let me turn things over to you.
Great. Thanks, Cory, and it's really good to be here. Normally, it's these first 15 seconds when I look out at the audience and I get worried that no one's paying attention or
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |